1.06
0.00%
+0.00
After Hours:
1.07
0.01
+0.94%
Allakos Inc stock is currently priced at $1.06, with a 24-hour trading volume of 418.42K.
It has seen a +0.00% increased in the last 24 hours and a -13.82% declined in the past month.
The chart indicates a potential bullish trend, as the stock is above the $1.06 pivot point. If it approaches the $1.08 resistance level, significant changes may occur.
Allakos Inc Stock (ALLK) Financials Data
Allakos Inc (ALLK) Net Income 2024
ALLK net income (TTM) was -$166.14 million for the quarter ending September 30, 2023, a +55.26% increase year-over-year.
Allakos Inc (ALLK) Cash Flow 2024
ALLK recorded a free cash flow (TTM) of -$139.91 million for the quarter ending September 30, 2023, a +56.55% increase year-over-year.
Allakos Inc (ALLK) Earnings per Share 2024
ALLK earnings per share (TTM) was -$1.92 for the quarter ending September 30, 2023, a +71.60% growth year-over-year.
Allakos Inc Stock (ALLK) Latest News
Allakos (ALLK): Strong Industry, Solid Earnings Estimate Revisions
Zacks Investment Research
Allakos Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
GlobeNewswire Inc.
Allakos Presents Preclinical Data Highlighting Inhibition of MRGPRX2-Mediated Mast Cell Activation with AK006 at AAAAI 2024
GlobeNewswire Inc.
Allakos Announces Publication Highlighting AK006 Mast Cell Inhibition
GlobeNewswire Inc.
Biotech Stock Roundup: VRTX/CRSP Gene Therapy Label Expansion, ALLK Falls on Update
Zacks Investment Research
Allakos (ALLK) Plummets 60% on Ending Development of Lead Drug
Zacks Investment Research
About Allakos Inc
Allakos Inc., a clinical stage biopharmaceutical company, focuses on developing therapeutic antibodies targeting allergic, inflammatory, and proliferative diseases. The company is developing AK002 for the treatment of eosinophilic gastritis and eosinophilic gastroenteritis, urticaria, indolent systemic mastocytosis, and severe allergic conjunctivitis. Allakos Inc. was founded in 2012 and is headquartered in San Carlos, California.
Cap:
|
Volume (24h):